Previous Next Accountability Why Are Patient Groups Silent on High Drug Prices? Abstract: Until advocates are willing to take on Big Pharma, reform efforts have no chance. Publication: The Washington Monthly Date Published: April 1, 2020 Author(s): Merrill Goozner View This Resource